These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 35505234)

  • 1. Nanotechnology in drug and gene delivery.
    Hamimed S; Jabberi M; Chatti A
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jul; 395(7):769-787. PubMed ID: 35505234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology in cancer therapy.
    Aslan B; Ozpolat B; Sood AK; Lopez-Berestein G
    J Drug Target; 2013 Dec; 21(10):904-13. PubMed ID: 24079419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.
    Wu W; Luo L; Wang Y; Wu Q; Dai HB; Li JS; Durkan C; Wang N; Wang GX
    Theranostics; 2018; 8(11):3038-3058. PubMed ID: 29896301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons learned from immunological characterization of nanomaterials at the Nanotechnology Characterization Laboratory.
    Dobrovolskaia MA
    Front Immunol; 2022; 13():984252. PubMed ID: 36304452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
    Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
    Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
    Kaur M; Nagpal M; Aggarwal G
    Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade.
    Sohail M; Guo W; Li Z; Xu H; Zhao F; Chen D; Fu F
    Curr Med Chem; 2021; 28(19):3753-3772. PubMed ID: 33019919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Design and Application of Nanomaterials as Drug Carriers in Cancer Treatment.
    Hou J; Sun X; Huang Y; Yang S; Liu J; Feng C; Ma J; Chen B
    Curr Med Chem; 2020; 27(36):6112-6135. PubMed ID: 31419927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
    Dilnawaz F
    Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative nano-carriers in anticancer drug delivery-a comprehensive review.
    Dong P; Rakesh KP; Manukumar HM; Mohammed YHE; Karthik CS; Sumathi S; Mallu P; Qin HL
    Bioorg Chem; 2019 Apr; 85():325-336. PubMed ID: 30658232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
    Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
    Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in active targeting of nanomaterials for anticancer drug delivery.
    Dutta B; Barick KC; Hassan PA
    Adv Colloid Interface Sci; 2021 Oct; 296():102509. PubMed ID: 34455211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
    Sufi SA; Pajaniradje S; Mukherjee V; Rajagopalan R
    Antioxid Redox Signal; 2019 Feb; 30(5):762-785. PubMed ID: 29334759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery Systems of Multiple Drugs Using Nanotechnology for Future Cancer Therapy.
    Fumoto S; Nishida K
    Chem Pharm Bull (Tokyo); 2020; 68(7):603-612. PubMed ID: 32611997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarrier Based Advances in Drug Delivery to Tumor: An Overview.
    Jain A; Kumari R; Tiwari A; Verma A; Tripathi A; Shrivastava A; Jain SK
    Curr Drug Targets; 2018; 19(13):1498-1518. PubMed ID: 29384060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.